Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study

Weersink, R. A., Taxis, K., Drenth, J. P. H., Houben, E., Metselaar, H. J. & Borgsteede, S. D., Apr-2019, In : Drug Safety. 42, 4, p. 539-546

Research output: Contribution to journalArticleAcademicpeer-review

  • Rianne A. Weersink
  • Katja Taxis
  • Joost P. H. Drenth
  • Eline Houben
  • Herold J. Metselaar
  • Sander D. Borgsteede
Patients with cirrhosis are at risk for adverse drug reactions (ADRs) due to altered pharmacokinetics and pharmacodynamics. We aimed to determine the prevalence of drug prescriptions and the potential safety of these prescriptions in a real-world cohort of patients with cirrhosis.
Original languageEnglish
Pages (from-to)539-546
JournalDrug Safety
Issue number4
Early online date24-Oct-2018
Publication statusPublished - Apr-2019

Download statistics

No data available

ID: 66748028